| scholarly article | Q13442814 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Muul LM | |
| Belldegrun A | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 206-214 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity | |
| P478 | volume | 48 |
| Q55337277 | A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes. |
| Q36366872 | A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma |
| Q28288235 | A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma |
| Q58620124 | Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies |
| Q37016470 | Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism |
| Q73740835 | Adoptive immunotherapy using specific cytotoxic T lymphocytes against human lung-cancer-engrafted severe combined immunodeficiency mice |
| Q37986559 | Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility? |
| Q70212105 | Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy |
| Q55313257 | Analysis of T cell receptor variability in fresh tumor-infiltrating lymphocytes from human head and neck cancer. |
| Q71688770 | Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma |
| Q67900635 | Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody |
| Q36355478 | Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor |
| Q43910178 | CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival |
| Q38147124 | Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms |
| Q41450394 | Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma |
| Q41769462 | Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype |
| Q54235837 | Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon alpha. |
| Q41654802 | Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies |
| Q41526891 | Cytokine Gene Transduction in the Immunotherapy of Cancer |
| Q55041914 | Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody. |
| Q36916513 | Defective Major Histocompatibility Complex Class I Expression in a Sarcomatoid Renal Cell Carcinoma Cell Line |
| Q37623812 | Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. |
| Q67993236 | Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations |
| Q67874470 | Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity |
| Q54366761 | Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma. |
| Q67903074 | Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma |
| Q61863605 | Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies |
| Q36621847 | Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer |
| Q43750011 | Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies |
| Q35982247 | Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer |
| Q34111789 | Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma |
| Q70766281 | Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients |
| Q68082500 | High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast |
| Q57209343 | Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes |
| Q37253572 | Human autologous tumor-specific T cells in malignant melanoma |
| Q36080640 | Human stomach carcinoma-specific T cells derived from the tumour-draining lymph nodes |
| Q35981896 | Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer |
| Q41349062 | Immunotherapy I: Cyclosine gene transfer strategies |
| Q37069569 | Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors |
| Q41648588 | In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma |
| Q45160055 | In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions |
| Q37350605 | In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial |
| Q72613367 | Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation |
| Q69215693 | Induction of lymphokine-activated killer cell against human leukemia cells in vitro |
| Q42389902 | Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing |
| Q34994511 | Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients |
| Q42383966 | LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes. |
| Q68083749 | Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid |
| Q34588908 | Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors |
| Q42443884 | Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma |
| Q51148789 | On the kinetics and optimal specificity of cytotoxic reactions mediated by T-lymphocyte clones. |
| Q57749194 | Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype |
| Q69609528 | Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice |
| Q70222239 | Progress and challenges in the global effort against cancer |
| Q37803895 | Rationale for immunotherapy of renal cell carcinoma |
| Q45359678 | Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes |
| Q69511459 | Renal allograft rejection: possible involvement of lymphokine-activated killer cells |
| Q70123208 | Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells |
| Q41503614 | Role of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) in peripheral blood mononuclear cell activation by human renal carcinoma cells |
| Q39512710 | The development of new immunotherapies for the treatment of cancer using interleukin-2. A review |
| Q41331141 | The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma |
| Q50875823 | The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro |
| Q72790073 | The immunobiological effects of interleukin-2 in vivo |
| Q73508775 | The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma |
| Q34052611 | The prognostic value of liver tumor T cell infiltrates |
| Q68802336 | Time course of changes in phenotypes of cultured tumor-infiltrating lymphocytes isolated from human colorectal cancer |
| Q41667067 | Tumor-Infiltrating CD3- NK Cells Are More Effective than CD3+ T Cells in Killing Autologous Melanoma Cells |
| Q41207532 | Tumor-infiltrating lymphocytes from nonrenal urological malignancies |
| Q43050911 | Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes |
| Q40849487 | Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications |
| Q55085114 | Viroimmunotherapy for Colorectal Cancer: Clinical Studies. |
Search more.